Literature DB >> 27413709

Lung cancer stem cells-characteristics, phenotype.

Georgia Hardavella1, Rachel George1, Tariq Sethi1.   

Abstract

Lung cancer remains a major cause of cancer-related deaths worldwide with unfavourable prognosis mainly due to the late stage of disease at presentation. High incidence and disease recurrence rates are a fact despite advances in treatment. Ongoing experimental and clinical observations suggest that the malignant phenotype in lung cancer is sustained by lung cancer stem cells (CSCs) which are putative stem cells situated throughout the airways that have the potential of initiating lung cancer formation. These cells share the common characteristic of increased proliferation and differentiation, long life span and resistance to chemotherapy and radiation therapy. This review summarises the current knowledge on their characteristics and phenotype.

Entities:  

Keywords:  Stem cells; characteristics; lung cancer; phenotype; stem cell markers

Year:  2016        PMID: 27413709      PMCID: PMC4931140          DOI: 10.21037/tlcr.2016.02.01

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


  60 in total

1.  Conditional clara cell ablation reveals a self-renewing progenitor function of pulmonary neuroendocrine cells.

Authors:  S D Reynolds; K U Hong; A Giangreco; G W Mango; C Guron; Y Morimoto; B R Stripp
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-06       Impact factor: 5.464

Review 2.  Lung cancer stem cells: tools and targets to fight lung cancer.

Authors:  A Eramo; T L Haas; R De Maria
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

Review 3.  Leukaemia stem cells and the evolution of cancer-stem-cell research.

Authors:  Brian J P Huntly; D Gary Gilliland
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

4.  Retinal oxidation activity and biological role of human cytosolic aldehyde dehydrogenase.

Authors:  A Yoshida; L C Hsu; V Davé
Journal:  Enzyme       Date:  1992

5.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

6.  Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance.

Authors:  Koji Okudela; Tetsukan Woo; Hideaki Mitsui; Michihiko Tajiri; Munetaka Masuda; Kenichi Ohashi
Journal:  Pathol Int       Date:  2012-12       Impact factor: 2.534

7.  CD166(pos) subpopulation from differentiated human ES and iPS cells support repair of acute lung injury.

Authors:  Boon Seng Soh; Dahai Zheng; Julie Su Li Yeo; Henry He Yang; Shi Yan Ng; Lan Hiong Wong; Wencai Zhang; Pin Li; Massimo Nichane; Atasha Asmat; Poo Sing Wong; Peng Cheang Wong; Lin Lin Su; Sakis A Mantalaris; Jia Lu; Wa Xian; Frank McKeon; Jianzhu Chen; Elaine Hsuen Lim; Bing Lim
Journal:  Mol Ther       Date:  2012-09-11       Impact factor: 11.454

8.  Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.

Authors:  Elaine Lai-Han Leung; Ronald R Fiscus; James W Tung; Vicky Pui-Chi Tin; Lik Cheung Cheng; Alan Dart-Loon Sihoe; Louis M Fink; Yupo Ma; Maria Pik Wong
Journal:  PLoS One       Date:  2010-11-19       Impact factor: 3.240

9.  Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.

Authors:  Ping Wang; Quanli Gao; Zhenhe Suo; Else Munthe; Steinar Solberg; Liwei Ma; Mengyu Wang; Nomdo Anton Christiaan Westerdaal; Gunnar Kvalheim; Gustav Gaudernack
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

10.  The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer.

Authors:  Saroj K Basak; Mysore S Veena; Scott Oh; Ge Huang; Eri Srivatsan; Min Huang; Sherven Sharma; Raj K Batra
Journal:  PLoS One       Date:  2009-06-12       Impact factor: 3.240

View more
  29 in total

Review 1.  CD133 as a regulator of cancer metastasis through the cancer stem cells.

Authors:  Geou-Yarh Liou
Journal:  Int J Biochem Cell Biol       Date:  2018-11-03       Impact factor: 5.085

2.  Targeting of Lung Cancer Stem Cell Self-Renewal Pathway by a Small Molecule Verrucarin J.

Authors:  Karen Udoh; Seema Parte; Kelsey Carter; Aaron Mack; Sham S Kakar
Journal:  Stem Cell Rev Rep       Date:  2019-08       Impact factor: 5.739

Review 3.  Lung cancer stem cells-origin, characteristics and therapy.

Authors:  D Prabavathy; Y Swarnalatha; Niveditha Ramadoss
Journal:  Stem Cell Investig       Date:  2018-03-14

4.  [Targeted killing of CD133+ lung cancer stem cells using paclitaxel-loaded PLGA-PEG nanoparticles with CD133 aptamers].

Authors:  L Pang; X Huang; L Zhu; H Xiao; M Li; H Guan; J Gao; H Jin
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-01-20

5.  EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumour colonization.

Authors:  Amador Gallardo; Aldara Molina; Helena G Asenjo; Lourdes Lopez-Onieva; Jordi Martorell-Marugán; Mencia Espinosa-Martinez; Carmen Griñan-Lison; Juan Carlos Alvarez-Perez; Francisca E Cara; Saul A Navarro-Marchal; Pedro Carmona-Sáez; Pedro P Medina; Juan Antonio Marchal; Sergio Granados-Principal; Antonio Sánchez-Pozo; David Landeira
Journal:  Oncogene       Date:  2022-06-09       Impact factor: 8.756

Review 6.  Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies.

Authors:  Yue Zheng; Laduona Wang; Limei Yin; Zhuoran Yao; Ruizhan Tong; Jianxin Xue; You Lu
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

7.  LW106, a novel indoleamine 2,3-dioxygenase 1 inhibitor, suppresses tumour progression by limiting stroma-immune crosstalk and cancer stem cell enrichment in tumour micro-environment.

Authors:  Rong Fu; Yi-Wei Zhang; Hong-Mei Li; Wen-Cong Lv; Li Zhao; Qing-Long Guo; Tao Lu; Stephen J Weiss; Zhi-Yu Li; Zhao-Qiu Wu
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

8.  Acquisition of Cancer Stem Cell-like Properties in Human Small Airway Epithelial Cells after a Long-term Exposure to Carbon Nanomaterials.

Authors:  Chayanin Kiratipaiboon; Todd A Stueckle; Rajib Ghosh; Liying W Rojanasakul; Yi Charlie Chen; Cerasela Zoica Dinu; Yon Rojanasakul
Journal:  Environ Sci Nano       Date:  2019-05-24

Review 9.  Cofilin-1 and Other ADF/Cofilin Superfamily Members in Human Malignant Cells.

Authors:  Sergey Shishkin; Lidia Eremina; Natalya Pashintseva; Leonid Kovalev; Marina Kovaleva
Journal:  Int J Mol Sci       Date:  2016-12-22       Impact factor: 5.923

10.  Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells.

Authors:  Xiaolong Huang; Jingsong Huang; Dewen Leng; Shuo Yang; Qi Yao; Jin Sun; Jun Hu
Journal:  World J Surg Oncol       Date:  2017-08-30       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.